
'Zaynich' antibiotic for multi-drug resistant infections to get USFDA approval next year: Wockhardt Chairman Habib ...
Dubai: Habib Khorakiwala, Chairman of Indian pharmaceutical company Wockhardt, on Friday said 'Zaynich,' its medicine for multi-drug resistant infections, is set to get the US Food and Drug Administration (USFDA) approval next year. Zaynich is a …